These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1339 related articles for article (PubMed ID: 16889069)
1. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
2. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system. Han Y; Tian H; He P; Chen X; Jing X Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100 [TBL] [Abstract][Full Text] [Related]
3. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles. Shi K; Cui F; Yamamoto H; Kawashima Y Pharmazie; 2008 Dec; 63(12):866-71. PubMed ID: 19177901 [TBL] [Abstract][Full Text] [Related]
4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
5. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation. Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168 [TBL] [Abstract][Full Text] [Related]
6. Novel approach for delivery of insulin loaded poly(lactide-co-glycolide) nanoparticles using a combination of stabilizers. Kumar PS; Saini TR; Chandrasekar D; Yellepeddi VK; Ramakrishna S; Diwan PV Drug Deliv; 2007 Nov; 14(8):517-23. PubMed ID: 18027181 [TBL] [Abstract][Full Text] [Related]
7. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method. Choi SH; Park TG Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477 [TBL] [Abstract][Full Text] [Related]
8. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
9. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Dillen K; Vandervoort J; Van den Mooter G; Ludwig A Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538 [TBL] [Abstract][Full Text] [Related]
11. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin. Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666 [TBL] [Abstract][Full Text] [Related]
12. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles. Packhaeuser CB; Kissel T J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938 [TBL] [Abstract][Full Text] [Related]
13. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles. He W; Horn SW; Hussain MD Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249 [TBL] [Abstract][Full Text] [Related]
14. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles. Bozdag S; Dillen K; Vandervoort J; Ludwig A J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924 [TBL] [Abstract][Full Text] [Related]
16. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761 [TBL] [Abstract][Full Text] [Related]
17. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres. Hsu YY; Hao T; Hedley ML J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910 [TBL] [Abstract][Full Text] [Related]
18. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272 [TBL] [Abstract][Full Text] [Related]
19. Alginate microspheres prepared by internal gelation: development and effect on insulin stability. Silva CM; Ribeiro AJ; Figueiredo IV; Gonçalves AR; Veiga F Int J Pharm; 2006 Mar; 311(1-2):1-10. PubMed ID: 16442757 [TBL] [Abstract][Full Text] [Related]
20. Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]